|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.60 USD | +0.88% |
|
-4.45% | +33.07% |
| 02:45pm | Stocks Rise Pre-Bell as President Trump Signals Optimism on Iran Deal Prospects | MT |
| 02:20pm | Fresh Records Eyed on Wall Street Pre-Bell; Asia Off, Europe Up | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.73 | 3.37 | 4.65 | 5.63 | 5.54 | |||||
Return on Total Capital | 3.93 | 5.07 | 7.47 | 9.21 | 8.87 | |||||
Return On Equity % | -1.89 | -3.7 | 13.11 | 18.47 | 14.55 | |||||
Return on Common Equity | -1.58 | -4.11 | 13.06 | 18.47 | 14.49 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 19.75 | 20.94 | 20.72 | 21.25 | 23.68 | |||||
SG&A Margin | 11.94 | 11.83 | 10.31 | 8.91 | 8.85 | |||||
EBITDA Margin % | 13.2 | 13.88 | 14.64 | 16.27 | 16.93 | |||||
EBITA Margin % | 9.05 | 9.92 | 11.38 | 13.14 | 13.56 | |||||
EBIT Margin % | 7.81 | 8.87 | 10.37 | 12.19 | 12.66 | |||||
Income From Continuing Operations Margin % | -1.61 | -2.73 | 7.72 | 10.81 | 9.46 | |||||
Net Income Margin % | -1.07 | -2.84 | 7.62 | 10.7 | 9.33 | |||||
Net Avail. For Common Margin % | -1.07 | -2.84 | 7.62 | 10.7 | 9.33 | |||||
Normalized Net Income Margin | 4.96 | 4.09 | 5.89 | 7.17 | 7.36 | |||||
Levered Free Cash Flow Margin | 8.27 | 6.74 | 9.37 | 6.91 | 4.07 | |||||
Unlevered Free Cash Flow Margin | 9.1 | 7.48 | 10.1 | 7.56 | 4.75 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.56 | 0.61 | 0.72 | 0.74 | 0.7 | |||||
Fixed Assets Turnover | 3.46 | 3.85 | 4.66 | 4.85 | 4.72 | |||||
Receivables Turnover (Average Receivables) | 4.3 | 4.43 | 4.89 | 4.88 | 5.05 | |||||
Inventory Turnover (Average Inventory) | 3.92 | 3.9 | 4.18 | 4.36 | 4.27 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.65 | 1.32 | 1.25 | 1.32 | 1.36 | |||||
Quick Ratio | 1.16 | 0.83 | 0.75 | 0.81 | 0.75 | |||||
Operating Cash Flow to Current Liabilities | 0.26 | 0.17 | 0.24 | 0.26 | 0.27 | |||||
Days Sales Outstanding (Average Receivables) | 84.89 | 82.36 | 74.59 | 74.94 | 72.35 | |||||
Days Outstanding Inventory (Average Inventory) | 93.17 | 93.47 | 87.38 | 83.9 | 85.43 | |||||
Average Days Payable Outstanding | 82.95 | 84.69 | 77.21 | 75.74 | 78.64 | |||||
Cash Conversion Cycle (Average Days) | 95.12 | 91.14 | 84.76 | 83.1 | 79.13 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 45.13 | 51.41 | 43.75 | 39.26 | 35.26 | |||||
Total Debt / Total Capital | 31.09 | 33.95 | 30.43 | 28.19 | 26.07 | |||||
LT Debt/Equity | 43.72 | 45.45 | 41.38 | 37.79 | 30.72 | |||||
Long-Term Debt / Total Capital | 30.12 | 30.02 | 28.78 | 27.14 | 22.71 | |||||
Total Liabilities / Total Assets | 52.57 | 57.51 | 57.99 | 55.54 | 53.5 | |||||
EBIT / Interest Expense | 5.91 | 7.44 | 8.82 | 11.66 | 11.55 | |||||
EBITDA / Interest Expense | 12.67 | 14.75 | 15.28 | 18.58 | 18.13 | |||||
(EBITDA - Capex) / Interest Expense | 9.51 | 10.82 | 11.2 | 14.19 | 13.95 | |||||
Total Debt / EBITDA | 2.2 | 2.01 | 1.48 | 1.24 | 1.22 | |||||
Net Debt / EBITDA | 0.78 | 1.14 | 0.9 | 0.62 | 0.54 | |||||
Total Debt / (EBITDA - Capex) | 2.93 | 2.74 | 2.02 | 1.62 | 1.58 | |||||
Net Debt / (EBITDA - Capex) | 1.03 | 1.55 | 1.23 | 0.81 | 0.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.98 | 3.19 | 20.56 | 9.11 | -0.34 | |||||
Gross Profit, 1 Yr. Growth % | 17.53 | 9.43 | 19.3 | 11.86 | 0.15 | |||||
EBITDA, 1 Yr. Growth % | 15.24 | 8.5 | 22.51 | 21.26 | 2.76 | |||||
EBITA, 1 Yr. Growth % | 38.43 | 13.1 | 31.48 | 25.96 | 1.68 | |||||
EBIT, 1 Yr. Growth % | 55.23 | 17.1 | 33.23 | 28.14 | 2.27 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -97.91 | 75.15 | -440.83 | 52.69 | -12.77 | |||||
Net Income, 1 Yr. Growth % | -97.8 | 174.43 | -423.29 | 53.32 | -13.13 | |||||
Normalized Net Income, 1 Yr. Growth % | -83.84 | -14.79 | 52.41 | 32.68 | 2.38 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -98.17 | 129.11 | -413.11 | 56.02 | -12.75 | |||||
Accounts Receivable, 1 Yr. Growth % | 1.54 | -1.31 | 19.84 | 0.53 | -7.56 | |||||
Inventory, 1 Yr. Growth % | -10 | 15.28 | 11.05 | -2.75 | 0 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.48 | -7.09 | 6.93 | 2.53 | 2.46 | |||||
Total Assets, 1 Yr. Growth % | -7.1 | -3.19 | 8.09 | 3.84 | 6.56 | |||||
Tangible Book Value, 1 Yr. Growth % | 88.17 | -9.62 | 19.93 | 33.63 | 26.26 | |||||
Common Equity, 1 Yr. Growth % | 15.02 | -2.94 | 6.77 | 9.94 | 11.48 | |||||
Cash From Operations, 1 Yr. Growth % | 82.06 | -20.47 | 62.18 | 8.82 | 14.35 | |||||
Capital Expenditures, 1 Yr. Growth % | -12.12 | 15.54 | 23.76 | 4.41 | -0.39 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 7.95 | -15.91 | 219.95 | -19.53 | -42.15 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 7.45 | -15.11 | 184.96 | -18.33 | -38.17 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 1.39 | 6.85 | 7.69 | 9.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -7.26 | 1.08 | 11.54 | 14.69 | 4.27 | |||||
Gross Profit, 2 Yr. CAGR % | -4.42 | 13.41 | 14.26 | 15.52 | 5.16 | |||||
EBITDA, 2 Yr. CAGR % | -5.37 | 11.82 | 20.22 | 23.08 | 11.98 | |||||
EBITA, 2 Yr. CAGR % | -2.96 | 25.13 | 29.5 | 30.44 | 13.61 | |||||
EBIT, 2 Yr. CAGR % | -0.09 | 34.83 | 33.8 | 32.64 | 14.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 10.35 | -80.85 | 144.33 | 128.13 | 15.41 | |||||
Net Income, 2 Yr. CAGR % | 30.8 | -75.41 | 197.86 | 122.64 | 15.41 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.11 | -62.89 | 22.82 | 44.92 | 16.55 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.35 | -79.67 | 165.97 | 121.03 | 16.67 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.53 | 0.11 | 8.75 | 9.76 | -3.6 | |||||
Inventory, 2 Yr. CAGR % | -7.08 | 1.86 | 13.15 | 3.92 | -1.38 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -10.21 | -7.29 | -0.33 | 4.71 | 2.49 | |||||
Total Assets, 2 Yr. CAGR % | -18.66 | -5.17 | 2.29 | 5.94 | 5.19 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.98 | 30.41 | 4.11 | 26.6 | 29.89 | |||||
Common Equity, 2 Yr. CAGR % | -17.76 | 5.66 | 1.8 | 8.34 | 10.7 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.67 | 20.33 | 13.57 | 32.85 | 11.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.91 | 0.77 | 19.58 | 13.68 | 1.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -11.45 | -4.73 | 22.17 | 64.52 | -32.15 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -10.16 | -4.49 | 20.06 | 55.73 | -28.59 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0.69 | 4.08 | 7.27 | 8.6 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.59 | -3.9 | 7.2 | 10.72 | 9.44 | |||||
Gross Profit, 3 Yr. CAGR % | 0.52 | -0.01 | 15.34 | 13.45 | 14.01 | |||||
EBITDA, 3 Yr. CAGR % | -0.25 | -0.96 | 16.7 | 20.58 | 16.24 | |||||
EBITA, 3 Yr. CAGR % | 3.03 | 2.12 | 29.39 | 28.33 | 20.49 | |||||
EBIT, 3 Yr. CAGR % | 6.64 | 5.34 | 36.87 | 31.9 | 22.12 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 5.25 | 28.72 | -50 | 108.89 | 65.58 | |||||
Net Income, 3 Yr. CAGR % | 3.94 | 67.45 | -41.96 | 138.71 | 62.69 | |||||
Normalized Net Income, 3 Yr. CAGR % | 26.44 | 10.66 | -37.94 | 26.04 | 29.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -15.66 | 38.34 | -49.38 | 122.65 | 62.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.22 | -5.51 | 6.29 | 5.94 | 3.65 | |||||
Inventory, 3 Yr. CAGR % | -4.86 | -0.15 | 4.84 | 7.58 | 2.6 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.92 | -9.18 | -2.77 | 0.62 | 3.95 | |||||
Total Assets, 3 Yr. CAGR % | -12.35 | -13.8 | -0.94 | 2.8 | 6.15 | |||||
Tangible Book Value, 3 Yr. CAGR % | -19.16 | 1.13 | 26.82 | 13.15 | 26.49 | |||||
Common Equity, 3 Yr. CAGR % | -5.31 | -13.09 | 6.03 | 4.44 | 9.38 | |||||
Cash From Operations, 3 Yr. CAGR % | 10.45 | -3.88 | 32.92 | 11.96 | 26.37 | |||||
Capital Expenditures, 3 Yr. CAGR % | -4.89 | -7.26 | 7.91 | 14.29 | 8.78 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -9.12 | -12.97 | 15 | 6.3 | 16.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -8.04 | -11.84 | 14.07 | 5.6 | 14.92 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0.46 | 2.7 | 5.27 | 8.02 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.4 | 4.25 | 2.2 | 3.14 | 6.02 | |||||
Gross Profit, 5 Yr. CAGR % | 6.67 | 7.25 | 5.81 | 5.94 | 13.77 | |||||
EBITDA, 5 Yr. CAGR % | 13.05 | 11.09 | 6.48 | 8.42 | 14.86 | |||||
EBITA, 5 Yr. CAGR % | 9.94 | 15.52 | 11.35 | 13.18 | 22.92 | |||||
EBIT, 5 Yr. CAGR % | 11.83 | 24.27 | 14.9 | 16.14 | 27.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 36.75 | 5.95 | 47.41 | 61.83 | -30.13 | |||||
Net Income, 5 Yr. CAGR % | - | 42.3 | 58.38 | 87.66 | -23.6 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.23 | 6.17 | 24.48 | 25.56 | -20.14 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 20.35 | 33.53 | 66.92 | -29.31 | |||||
Accounts Receivable, 5 Yr. CAGR % | 20.33 | -1.72 | 1.41 | 0.33 | 2.22 | |||||
Inventory, 5 Yr. CAGR % | 4.3 | 0.35 | 1.97 | 1.46 | 2.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.64 | -5.32 | -1.89 | -3.86 | -0.7 | |||||
Total Assets, 5 Yr. CAGR % | 10.2 | -9.56 | -6.76 | -6.39 | 1.47 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.14 | -18.63 | -10.55 | 10.64 | 28.04 | |||||
Common Equity, 5 Yr. CAGR % | 0.19 | 0.16 | -2.53 | -5.08 | 7.87 | |||||
Cash From Operations, 5 Yr. CAGR % | 55.39 | 18.77 | 11.69 | 9.4 | 23.92 | |||||
Capital Expenditures, 5 Yr. CAGR % | 15.09 | 8.26 | 4.23 | 0.61 | 5.5 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 58 | -3.42 | 1.13 | -2.32 | -6.42 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 76.63 | -0.4 | 1.44 | -1.85 | -5.37 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 15.84 | 1.61 | 3.13 | 5.02 |
- Stock Market
- Equities
- BKR Stock
- Financials Baker Hughes Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















